Lonza Group AG (SWX: LONN)
Health Care · Life Sciences Tools & Services · CH
CHF575.60
+0.59% today · +5.1% 1Y
Lonza Group AG (SWX: LONN) operates in the Life Sciences Tools & Services industry within the Health Care sector. The company is valued at $48.10B and employs 20,141 people.
Over the last twelve months the share price has gained 5.1%, trading between 454.60 and 597.80.
Tweenvest scores Lonza Group AG across four factors: quality 68/100, value 46/100, growth 49/100, dividend 71/100. Its strongest factor is dividend.
LONN price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $48.10B
- Revenue (TTM)
- $8.50B
- P/E
- 36.99
- EPS
- -1.57
- Dividend yield
- 0.89%
- Beta (5Y)
- 0.81
- 52-week high
- CHF597.80
- 52-week low
- CHF454.60
- Avg volume (3M)
- —
- Shares outstanding
- 69.84M
- Employees
- 20,141
- Next earnings
- —
About Lonza Group AG
Lonza Group AG, together with its subsidiaries, operates as a contract development and manufacturing organization for pharma and biotech companies in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally. It operates through Integrated Biologics; Advanced Synthesis; and Specialized Modalities segments. The Integrated Biologics segment offers CDMO biologics services from clinical development, drug substance, and drug product manufacturing; and operates mammalian and drug product platforms. Its Advanced Synthesis segment manufactures antibody-drug conjugates (ADCs) and other bioconjugates, small molecules, and highly potent active pharmaceutical ingredients; and operates small molecules and bioconjugates platforms. The Specialized Modalities segment operates various technologies, such as spanning cell & gene, microbial, bioscience, and mRNA. Lonza Group AG was incorporated in 1897 and is headquartered in Basel, Switzerland.
- ISIN
- CH0013841017
- Founded
- 1897
- Listed since
- Nov 1, 1999
- Exchange
- SIX Swiss Exchange
- Currency
- CHF
Other Life Sciences Tools & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Thermo Fisher Scientific Inc.NYSE: TMO | $243.30B | $657.72 | -0.05% |
| Danaher CorporationNYSE: DHR | $154.52B | $220.27 | +0.21% |
| WuXi AppTec Co., Ltd.SHSE: 603259 | $70.61B | CN¥157.80 | -2.59% |
| Agilent Technologies, Inc.NYSE: A | $48.08B | $171.67 | +0.66% |
| IQVIA Holdings Inc.NYSE: IQV | $42.78B | $261.57 | +0.65% |
| Waters CorporationNYSE: WAT | $42.62B | $430.59 | -0.73% |
| Illumina, Inc.NasdaqGS: ILMN | $42.00B | $272.66 | -1.98% |
| Samsung Biologics Co.,Ltd.KOSE: A207940 | $41.93B | ₩1,219,000.00 | -9.97% |
Figures last refreshed Oct 11, 2026.